During the past decade, Expertia S.A- Mautalen Salud e Investigacion conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 13 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Expertia S.A- Mautalen Salud e Investigacion" #1 sponsor was "Eli Lilly and Company" with 18 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Takeda" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Expertia S.A- Mautalen Salud e Investigacion" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Expertia S.A- Mautalen Salud e Investigacion" are "Ulcerative Colitis" (5 trials), "Obesity" (4 trials), "Colitis, Ulcerative" (3 trials), "Overweight" (3 trials) and "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "Expertia S.A- Mautalen Salud e Investigacion" in a lesser frequency.

Most popular intervention types in "Expertia S.A- Mautalen Salud e Investigacion" are "Drug" (25 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Tirzepatide" (8 trials), "Insulin Degludec" (3 trials), "Insulin Efsitora Alfa" (3 trials) and "Mirikizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Expertia S.A- Mautalen Salud e Investigacion" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Expertia S.A- Mautalen Salud e Investigacion". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Expertia S.A- Mautalen Salud e Investigacion, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Expertia S.A- Mautalen Salud e Investigacion, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".